Archive - January 2020
AZ’s Imfinzi scores orphan drug status in liver cancer
FDA approves Horizon’s thyroid eye disease drug ahead of schedule
Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price
EU group calls for ‘targeted actions’ to mitigate impact of Brexit
UPDATED: J&J’s $8bn Risperdal judgment reduced to $6.8m
FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
PhoreMost enlists Otsuka in multi-project drug discovery collab
EU grants conditional approval to Roche’s lymphoma drug Polivy